The use of genetic sonography to reduce the need for amniocentesis in women at high-risk for Down syndrome

Seminars in Perinatology

Volumn 27, Issue 2, 2003, Pages 152-159

  Yeo, Lami ^a   Vintzileos, Anthony M ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMNIOCENTESIS; ANEUPLOIDY; DECISION MAKING; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FEMALE; FETUS; FETUS ECHOGRAPHY; GENETIC MARKER; GENETIC SCREENING; GENETIC SONOGRAPHY; HIGH RISK PREGNANCY; HUMAN; MATERNAL AGE; PATIENT COUNSELING; PATIENT RIGHT; PATIENT SATISFACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SECOND TRIMESTER PREGNANCY;

EID: 0038708375     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/sper.2003.50014     Document Type: Review

References (28)

1. Egan JF, Benn P, Borgida AF, et al: Efficacy of screening for fetal Down syndrome in the United States from 1974 to 1997. Obstet Gynecol 96:979-985, 2000
2. Vintzileos AM, Egan JF: Adjusting the risk for trisomy 21 on the basis of second trimester ultrasonography. Am J Obstet Gynecol 172:837-844, 1995
3. Haddow JE, Palomaki GE, Knight GJ, et al: Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. N Engl J Med 330:114-118, 1994
4. Nyberg DA, Kramer D, Resta RG, et al: Prenatal sonographic findings of trisomy 18: Review of 47 cases. J Ultrasound Med 2:103-113, 1993
5. Yeo L, Guzman ER, Vintzileos AM, et al: The value of a complete anatomic survey in the sonographic detection of trisomy 18. Am J Obstet Gynecol 180: S166, 1999 (abstr)
6. Lehman CD, Nyberg DA, Winter TC, et al: Trisomy 13 syndrome: Prenatal ultrasound findings in a review of 33 cases. Radiology 194:217-222, 1995
7. Vintzileos AM, Guzman ER, Smulian JC, et al: Indication-specific accuracy of second-trimester genetic ultrasonography for the detection of trisomy 21. Am J Obstet Gynecol 181:1045-1048, 1999
8. Benacerraf BR, Neuberg D, Bromley B, et al: Sonographic scoring index for prenatal detection of chromosomal abnormalities. J Ultrasound Med 11:449-458, 1992
9. Nadel AS, Bromley B, Frigoletto FD, et al: Can the presumed risk of autosomal trisomy be decreased in fetuses of older women following a normal sonogram? J Ultrasound Med 14:297-302, 1995
10. DeVore GR, Alfi O: The use of color Doppler ultrasound to identify fetuses at increased risk for trisomy 21: An alternative for high-risk patients who decline genetic amniocentesis. Obstet Gynecol 85:378-386, 1995
11. Nyberg DA, Luthy DA, Cheng EY, et al: Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers. Am J Obstet Gynecol 173:1030-1035, 1995
12. Vintzileos AM, Campbell WA, Rodis JF, et al: The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21. Obstet Gynecol 87:948-952, 1996
13. Bahado-Singh RO, Tan A, Deren O, et al: Risk of Down syndrome and any clinically significant chromosome defect in pregnancies with abnormal triple-screen and normal targeted ultrasonographic results. Am J Obstet Gynecol 175:824-829, 1996
14. Bromley B, Lieberman E, Benacerraf BR: The incorporation of maternal age into the sonographic scoring index for the detection at 14-20 weeks of fetuses with Down syndrome. Ultrasound Obstet Gynecol 10:321-324, 1997
15. Verdin SM, Economides DL: The role of ultrasonographic markers for trisomy 21 in women with positive serum biochemistry. Br J Obstet Gynaecol 105:63-67, 1998
16. Nyberg DA, Luthy DA, Resta RG, et al: Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: Description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol 12:8-14, 1998
17. Sohl BD, Scioscia AL, Budorick NE, et al: Utility of minor ultrasonographic markers in the prediction of abnormal fetal karyotype at a prenatal diagnostic center. Am J Obstet Gynecol 181:898-903, 1999
18. Wax JR, Guilbert J, Mather J, et al: Efficacy of community-based second trimester genetic ultrasonography in detecting the chromosomally abnormal fetus. J Ultrasound Med 19:689-694, 2000
19. Devore GR, Romero R: Combined use of genetic sonography and maternal serum triple-marker screening: an effective method for increasing the detection of trisomy 21 in women younger than 35 years. J Ultrasound Med 20:645-654, 2001
20. Persutte WH, Hobbins JC, Nyberg DA, et al: Trisomy 21 multicenter collaborative project. Am J Obstet Gynecol 178: S22, 1998 (abstr)
21. Hobbins JC, Lezotte DC, Persutte WH, et al: An eight center study to evaluate the utility of mid-term genetic ultrasounds among high risk pregnancies. J Ultrasound Med 22:33-38, 2003
22. Smith-Bindman R, Hosmer W, Feldstein VA, et al: Second-trimester ultrasound to detect fetuses with Down syndrome: A meta-analysis. JAMA 285:1044-1055, 2001
23. Hobbins JC, Bahado-Singh RO, Lezotte DC: The genetic sonogram in screening for Down syndrome: response to the JAMA study. J Ultrasound Med 20:269-272, 2001
24. Vintzileos AM, Guzman ER, SmulianJC, et al: Choice of second-trimester genetic sonogram for detection of trisomy 21. Obstet Gynecol 90:187-190, 1997
25. Deren O, Mahoney MJ, Copel JA, et al: Subtle ultrasonographic anomalies: Do they improve the Down syndrome detection rate? Am J Obstet Gynecol 178:441-445, 1998
26. Pinette MG, Garrett J, Salvo A, et al: Normal midtrimester (17-20 weeks) genetic sonogram decreases amniocentesis rate in a high-risk population. J Ultrasound Med 20:639-644, 2001
27. Vintzileos AM, Guzman ER, Smulian JC, et al: Down syndrome risk estimation after normal genetic sonography. Am J Obstet Gynecol 187:1226-1229, 2002
28. Vintzileos AM, Guzman ER, Smulian JC, et al: Second-trimester genetic sonography in patients with advanced maternal age and normal triple screen. Obstet Gynecol 99:993-995, 2002